Vector Biolabs
Private Company
Funding information not available
Overview
Vector Biolabs is a specialized service provider in the viral vector space, offering custom AAV and adenovirus production for research and preclinical applications. Its business model is built on providing high-quality, fast-turnaround vector construction and a large catalog of pre-made vectors, primarily serving the research community rather than developing its own therapeutics. The company is positioned as a critical enabler for the growing gene therapy and neuroscience research sectors, with a reputation for quality evidenced by testimonials from leading research institutions.
Technology Platform
Custom design and production platform for AAV and adenovirus viral vectors, featuring a large genetic library (>100k cDNA), fast turnaround services, and expertise in plasmid packaging and vector engineering for research applications.
Opportunities
Risk Factors
Competitive Landscape
Vector Biolabs competes in the viral vector CRO space against large, diversified service providers (e.g., Lonza, Charles River) and other specialized boutiques. Its differentiation lies in its focused expertise on AAV/adenovirus, extensive pre-made catalog, and emphasis on speed and collaborative custom design for the research market.